Defining Cancer Drug Development Part I: A Discussion with FDA's Pazdur

FDA’s cancer czar Richard Pazdur is a lightning rod for critics who say he’s keeping potentially life-saving drugs off the market because regulatory standards are too high. He says just look at the data.